A. Cottereau

SUBCUTANEOUS EPCORITAMAB INDUCES DEEP, DURABLE COMPLETE REMISSIONS IN RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA: LONGER FOLLOW‐UP FROM THE PIVOTAL EPCORE NHL‐1 TRIAL

M. Hutchings, C. Cheah, C. Thieblemont, 2023, Hematological Oncology.

Risk stratification in diffuse large B cell lymphoma using lesion dissemination and metabolic tumor burden calculated from baseline PET/CT.

I. Buvat, L. Vercellino, O. Casasnovas, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

Metabolic tumor volume predicts outcome in advanced stage follicular lymphoma patients from the Relevance trial.

I. Flinn, F. Morschhauser, O. Casasnovas, 2023, Annals of oncology : official journal of the European Society for Medical Oncology.